The T. Rowe Price European Select Equity Strategy has been a strong performer in volatile markets since its debut two years ago. We believe that most of the explanation for this success comes down to three important factors. Innovation-focused investment philosophies and processes, and leveraging the investment edge provided by high-quality in-house research. Lessons learned from implementing and testing our approach. And the opportunities offered by large and complex markets.
As the strategy enters its third year, the three dynamics will be seen as shaping the outlook for European equity space and in-space opportunities.
- A region rich in innovation and destruction
- The cutting edge of sustainability
- Changes in the market cycle
Europe is full of innovation and destruction
Our aim is to identify, fully understand and support high quality growth companies that are innovators, disruptors and to the right of change, with quality that does not know national or regional boundaries.
Innovation is not the protection of the United States or Asia. This is probably the view that has been favored by the rise of FAANG (Facebook, Apple, Amazon, Netflix, Alphabet) and the outstanding performance of the last decade. Europe is perceived to be plagued by mostly traditional businesses and dysfunctional banks, and in fact, the number of state-of-the-art manufacturers and disruptive healthcare and information technology companies is increasing. I am.
The innovation theme is central to building a centralized portfolio within Europe Select. Here are some examples of top investments:
- ASML Holding monopolizes next-generation high-end lithography tools (EUV machines) for semiconductor manufacturers. They will adopt this new machine to increase the number of transistors on the chip and power cutting-edge applications.
- Siemens is a global industrial company operating in the electricity and gas, digital factories, process industries, and the renewable energy market benefiting from the so-called Fourth Industrial Revolution.
- Lonza Group, a leading pharmaceutical company contract manufacturer and Swiss company with a competitive advantage in the rapidly expanding field of biopharmaceutical manufacturing.
- Teleperformance is a global customer experience provider that has become an integral part of the fast-growing digital economy.
Professional clients only. No further distribution is possible.
This material is provided for general information purposes only. This material does not undertake to compose or provide advice of any nature, including trustee investment advice, and future investors will provide independent legal, financial and tax advice before making investment decisions. We recommend that you ask. T. Rowe Price Associates, Inc. Companies in the T. Rowe Price group, including and / or its affiliates, are T. Receive revenue from RowePrice’s investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and the income from it can fluctuate. Investors may recoup less than their investment.
This material does not constitute a distribution, offer, invitation, personal or general recommendation or solicitation to buy or sell securities or conduct any particular investment activity in any jurisdiction. This material has not been reviewed by regulatory agencies in any jurisdiction.
The information and opinions presented are obtained or derived from sources that are considered reliable and up-to-date. However, we cannot guarantee the accuracy or completeness of the source. There is no guarantee that the predictions made will come true. The views contained herein are dated as stated in the material and are subject to change without notice. These views may differ from those of other T. Rowe Price Group companies and / or affiliates. Under any circumstances, T. You may not copy or redistribute all or part of the material without the consent of RowePrice.
This material is not intended for use by anyone in a jurisdiction that prohibits or restricts the distribution of the material, and in certain countries the material is provided upon specific request.
It is not intended to be distributed to individual investors in any jurisdiction.
This material is published and approved by EC4N 4TZ, approved and regulated by the Financial Conduct Authority of the United Kingdom, and T. Rowe Price International Ltd, located at 60 Queen Victoria Street, London. Professional clients only.
© 2021T. Low price. all rights reserved. Designed by T. ROWE PRICE, INVEST WITH CONFIDENCE, and Bighorn sheep. RowePrice Group, Inc. Is a trademark or registered trademark of.
Three dynamics that shape Europe’s promising prospects
https://www.investmentweek.co.uk/advertisement/4039278/industry-voice-dynamics-shaping-promising-outlook-europe Three dynamics that shape Europe’s promising prospects